Cerus Corp (CERS) Stock Price

CERSStock

$2.72+113.49%52W

Market Cap$548.15M

P/E—

PEG Ratio—

Div yield—

Beta1.82

CERS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-2.34%

Price vs S&P 500 (4W)-10.93%

VGM Score49.41

P/CF (Annual)118.32x

Book Value / Share (Quarterly)$0.35

P/TBV (Annual)11.14x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.48%

Cash Flow / Share (Quarterly)$-0.01

Price vs S&P 500 (YTD)18.62%

Gross Margin (TTM)57.16%

Net Profit Margin (TTM)-2.73%

EPS (TTM)$-0.03

10-Day Avg Trading Volume2.54M

EPS Excl Extra (TTM)$-0.03

Revenue Growth (5Y)15.41%

EPS (Annual)$-0.08

ROI (Annual)-10.55%

Gross Margin (Annual)59.86%

Net Profit Margin (5Y Avg)-18.80%

Cash / Share (Quarterly)$0.28

Revenue Growth QoQ (YoY)5.28%

ROA (Last FY)-7.04%

Revenue Growth TTM (YoY)14.61%

EBITD / Share (TTM)$0.00

ROE (5Y Avg)-52.08%

Operating Margin (TTM)-0.65%

Cash Flow / Share (Annual)$0.01

P/B Ratio8.17x

P/B Ratio (Quarterly)8.36x

Net Income / Employee (Annual)$-56,800

EV / Revenue (TTM)2.50x

Net Interest Coverage (TTM)-0.59x

ROA (TTM)-3.14%

EV / EBITDA (TTM)9382.83x

EPS Incl Extra (Annual)$-0.08

Current Ratio (Annual)1.73x

Quick Ratio (Quarterly)1.02x

3-Month Avg Trading Volume2.77M

52-Week Price Return113.49%

EV / Free Cash Flow (Annual)558.90x

Revenue / Employee (TTM)$901,900

Tangible BV / Share (Quarterly)$0.62

P/S Ratio (Annual)2.45x

Asset Turnover (Annual)1.05x

52-Week High$3.47

Operating Margin (5Y Avg)-15.13%

EPS Excl Extra (Annual)$-0.08

CapEx CAGR (5Y)18.15%

Tangible BV CAGR (5Y)2.02%

26-Week Price Return8.91%

Quick Ratio (Annual)1.12x

13-Week Price Return-1.82%

Total Debt / Equity (Annual)1.31x

Current Ratio (Quarterly)1.83x

Enterprise Value$619.27M

Revenue / Share Growth (5Y)11.98%

Asset Turnover (TTM)1.15x

Book Value / Share Growth (5Y)-11.54%

Revenue / Employee (Annual)$850,200

Inventory Turnover (Annual)1.99x

Pretax Margin (Annual)-6.54%

Cash / Share (Annual)$0.43

3-Month Return Std Dev73.94%

Gross Margin (5Y Avg)60.54%

Net Income / Employee (TTM)$-24,700

ROE (Last FY)-24.33%

Net Interest Coverage (Annual)0.16x

EPS Basic Excl Extra (Annual)$-0.08

P/FCF (TTM)114.76x

Receivables Turnover (TTM)7.95x

EV / Free Cash Flow (TTM)512.50x

Total Debt / Equity (Quarterly)0.93x

EPS Incl Extra (TTM)$-0.03

Receivables Turnover (Annual)7.77x

ROI (TTM)-4.66%

P/S Ratio (TTM)2.31x

Pretax Margin (5Y Avg)-18.64%

Revenue / Share (Annual)$1.23

Tangible BV / Share (Annual)$0.62

Price vs S&P 500 (52W)95.18%

Year-to-Date Return30.58%

5-Day Price Return-2.54%

EPS Normalized (Annual)$-0.08

ROA (5Y Avg)-15.79%

Net Profit Margin (Annual)-6.68%

Month-to-Date Return25.12%

Cash Flow / Share (TTM)$-0.26

EBITD / Share (Annual)$-0.04

Operating Margin (Annual)-3.71%

LT Debt / Equity (Annual)0.63x

P/CF (TTM)236.79x

ROI (5Y Avg)-24.05%

LT Debt / Equity (Quarterly)0.50x

EPS Basic Excl Extra (TTM)$-0.03

P/TBV (Quarterly)11.14x

P/B Ratio (Annual)6.16x

Inventory Turnover (TTM)1.77x

Pretax Margin (TTM)-2.60%

Book Value / Share (Annual)$0.33

Price vs S&P 500 (13W)-4.62%

Beta1.82x

P/FCF (Annual)516.54x

Revenue / Share (TTM)$1.24

ROE (TTM)-10.31%

52-Week Low$1.17

vGradeD

gGradeC

mGradeB

vgmGradeC

CERS Earnings Surprise History

Q2 25-0.03est. -0.02

Q3 250.00est. -0.03

Q4 25-0.01est. -0.01

Q1 26-0.01est. -0.04

Q2 26-0.01est. -0.01

CERS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

4.22

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
CERSCerus Corp	D	C	B	$2.72
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16
SIShoulder Innovations, Inc.	—	B	A	$22.32

About Cerus Corp

Cerus Corp manufactures pathogen-reduction systems for blood transfusion safety, primarily through its INTERCEPT platelet and plasma products. The company operates globally across the United States, Europe, the Middle East, and select international markets. Blood safety represents its sole business focus and revenue driver.